Yandan Yang
Yandan Yang
1Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892 USA
1,#,
Arnold Bolomsky
Arnold Bolomsky
1Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892 USA
1,#,
Thomas Oellerich
Thomas Oellerich
2Department of Medicine II, Heamatology/Oncology, Goethe University, 60323 Frankfurt, Germany
2,#,
Ping Chen
Ping Chen
1Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892 USA
1,#,
Michele Ceribelli
Michele Ceribelli
3Division of Preclinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Rockville, MD 20850 USA
3,
Björn Häupl
Björn Häupl
2Department of Medicine II, Heamatology/Oncology, Goethe University, 60323 Frankfurt, Germany
2,
George W Wright
George W Wright
4Biometric Research Branch, DCTD, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892 USA
4,
James D Phelan
James D Phelan
1Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892 USA
1,
Da Wei Huang
Da Wei Huang
1Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892 USA
1,
James W Lord
James W Lord
1Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892 USA
1,
Callie K Van Winkle
Callie K Van Winkle
1Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892 USA
1,
Xin Yu
Xin Yu
1Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892 USA
1,
Jan Wisniewski
Jan Wisniewski
5Experimental Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892 USA
5,
James Q Wang
James Q Wang
1Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892 USA
1,
Frances A Tosto
Frances A Tosto
3Division of Preclinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Rockville, MD 20850 USA
3,
Erin Beck
Erin Beck
3Division of Preclinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Rockville, MD 20850 USA
3,
Kelli Wilson
Kelli Wilson
3Division of Preclinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Rockville, MD 20850 USA
3,
Crystal McKnight
Crystal McKnight
3Division of Preclinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Rockville, MD 20850 USA
3,
Jameson Travers
Jameson Travers
3Division of Preclinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Rockville, MD 20850 USA
3,
Carleen Klumpp-Thomas
Carleen Klumpp-Thomas
3Division of Preclinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Rockville, MD 20850 USA
3,
Grace A Smith
Grace A Smith
6Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892 USA
6,
Stefania Pittaluga
Stefania Pittaluga
6Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892 USA
6,
Irina Maric
Irina Maric
7Hematology Service, Department of Laboratory Medicine, National Institutes of Health Clinical Center, Bethesda, MD 20892 USA
7,
Dickran Kazandjian
Dickran Kazandjian
8Department of Medicine, University of Miami Health System, Miami, FL 33136 USA
8,
Craig J Thomas
Craig J Thomas
1Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892 USA
3Division of Preclinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Rockville, MD 20850 USA
1,3,
Ryan M Young
Ryan M Young
1Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892 USA
1,✉
1Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892 USA
2Department of Medicine II, Heamatology/Oncology, Goethe University, 60323 Frankfurt, Germany
3Division of Preclinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Rockville, MD 20850 USA
4Biometric Research Branch, DCTD, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892 USA
5Experimental Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892 USA
6Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892 USA
7Hematology Service, Department of Laboratory Medicine, National Institutes of Health Clinical Center, Bethesda, MD 20892 USA
8Department of Medicine, University of Miami Health System, Miami, FL 33136 USA
Subject terms: Myeloma, Cell signalling, Oncogenes
© This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply 2022
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
